These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3490339)

  • 21. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.
    Bolhuis PA; Sakariassen KS; Sander HJ; Bouma BN; Sixma JJ
    J Lab Clin Med; 1981 Apr; 97(4):568-76. PubMed ID: 6782184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
    Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
    J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor.
    Bolhuis PA; Sakariassen KS; Sixma JJ
    Haemostasis; 1979; 8(3-5):312-23. PubMed ID: 315905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
    Potter EV; Shaughnessy MA; Green D
    Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased prevalence of mitral valve prolapse in patients with migraine.
    Spence JD; Wong DG; Melendez LJ; Nichol PM; Brown JD
    Can Med Assoc J; 1984 Dec; 131(12):1457-60. PubMed ID: 6498701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand syndromes and mitral-valve prolapse; linked mesenchymal dysplasias.
    Pickering NJ; Brody JI; Barrett MJ
    N Engl J Med; 1981 Jul; 305(3):131-4. PubMed ID: 6787425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Beta-thromboglobulin and platelet regeneration time in children with mitral valve prolapse].
    Cudillo L; Laghi F; Landolfi R; Leone G; Astore S; Pelargonio S; Bizzi B
    G Ital Cardiol; 1983 Oct; 13(10):215-8. PubMed ID: 6199249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
    Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
    PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.